U.S. flag

An official website of the United States government

NM_018475.5(TMEM165):c.376C>T (p.Arg126Cys) AND TMEM165-congenital disorder of glycosylation

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Aug 31, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000029181.8

Allele description [Variation Report for NM_018475.5(TMEM165):c.376C>T (p.Arg126Cys)]

NM_018475.5(TMEM165):c.376C>T (p.Arg126Cys)

Gene:
TMEM165:transmembrane protein 165 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4q12
Genomic location:
Preferred name:
NM_018475.5(TMEM165):c.376C>T (p.Arg126Cys)
HGVS:
  • NC_000004.12:g.55411782C>T
  • NG_032881.1:g.20870C>T
  • NM_018475.5:c.376C>TMANE SELECT
  • NP_060945.2:p.Arg126Cys
  • NC_000004.11:g.56277949C>T
  • NM_018475.4:c.376C>T
  • NR_073070.2:n.712C>T
  • Q9HC07:p.Arg126Cys
Protein change:
R126C; ARG126CYS
Links:
UniProtKB: Q9HC07#VAR_068446; OMIM: 614726.0003; dbSNP: rs387907222
NCBI 1000 Genomes Browser:
rs387907222
Molecular consequence:
  • NM_018475.5:c.376C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_073070.2:n.712C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
TMEM165-congenital disorder of glycosylation
Synonyms:
CDG IIk; Congenital disorder of glycosylation type 2k; TMEM165-CDG
Identifiers:
MONDO: MONDO:0013870; MedGen: C3553571; Orphanet: 314667; OMIM: 614727

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000051826OMIM
no assertion criteria provided
Pathogenic
(Jul 13, 2012)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000958962Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 31, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

TMEM165 deficiency causes a congenital disorder of glycosylation.

Foulquier F, Amyere M, Jaeken J, Zeevaert R, Schollen E, Race V, Bammens R, Morelle W, Rosnoblet C, Legrand D, Demaegd D, Buist N, Cheillan D, Guffon N, Morsomme P, Annaert W, Freeze HH, Van Schaftingen E, Vikkula M, Matthijs G.

Am J Hum Genet. 2012 Jul 13;91(1):15-26. doi: 10.1016/j.ajhg.2012.05.002. Epub 2012 Jun 7.

PubMed [citation]
PMID:
22683087
PMCID:
PMC3397274

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From OMIM, SCV000051826.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In an American girl with congenital disorder of glycosylation type 2k (CDG2K; 614727), Foulquier et al. (2012) identified compound heterozygosity for 2 mutations in the TMEM165 gene: a 376C-T transition resulting in an arg126-to-cys (R126C) substitution, and a 910G-A transition resulting in a gly304-to-arg (G304R; 614726.0004) substitution. Both affected residues are highly conserved. The patient had short stature, facial dysmorphism, wrinkled skin, abnormal fat distribution, dysplastic toenails, amelogenesis imperfecta, and multiple skeletal anomalies. Patient fibroblasts showed decreased immunostaining for TMEM165 compared to control.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000958962.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024